Cargando…
Declining in efficacy of a three-day combination regimen of mefloquine-artesunate in a multi-drug resistance area along the Thai-Myanmar border
BACKGROUND: Declining in clinical efficacy of artesunate-mefloquine combination has been documented in areas along the eastern border (Thai-Cambodian) of Thailand. In the present study, the clinical efficacy of the three-day combination regimen of artesunate-mefloquine as first-line treatment for ac...
Autores principales: | Na-Bangchang, Kesara, Ruengweerayut, Ronnatrai, Mahamad, Poonuch, Ruengweerayut, Kulaya, Chaijaroenkul, Wanna |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959072/ https://www.ncbi.nlm.nih.gov/pubmed/20929590 http://dx.doi.org/10.1186/1475-2875-9-273 |
Ejemplares similares
-
Population pharmacokinetics of mefloquine given as a 3-day artesunate–mefloquine in patients with acute uncomplicated Plasmodium falciparum malaria in a multidrug-resistant area along the Thai–Myanmar border
por: Hoglund, Richard M., et al.
Publicado: (2018) -
Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010
por: Muhamad, Poonuch, et al.
Publicado: (2011) -
Four years’ monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border
por: Phompradit, Papichaya, et al.
Publicado: (2014) -
Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity
por: Na-Bangchang, Kesara, et al.
Publicado: (2013) -
Population pharmacokinetics of a three-day chloroquine treatment in patients with Plasmodium vivax infection on the Thai-Myanmar border
por: Höglund, Richard, et al.
Publicado: (2016)